BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35057861)

  • 1. SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway.
    Wu F; Xiong G; Chen Z; Lei C; Liu Q; Bai Y
    Hereditas; 2022 Jan; 159(1):6. PubMed ID: 35057861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S
    Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SLC3A2 as a Potential Therapeutic Target of Osteoarthritis Involved in Ferroptosis by Integrating Bioinformatics, Clinical Factors and Experiments.
    Liu H; Deng Z; Yu B; Liu H; Yang Z; Zeng A; Fu M
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte.
    Chen Z; Li R; Fang M; Wang Y; Bi A; Yang L; Song T; Li Y; Li Q; Lin B; Jia Y; Fu S; Fu S; Xiong H
    Int J Med Sci; 2023; 20(8):1060-1078. PubMed ID: 37484811
    [No Abstract]   [Full Text] [Related]  

  • 5. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting SLC3A2 subunit of system X
    Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
    Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
    Zhang XJ; Jia SS
    Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids regulate mTOR pathway and milk protein synthesis in a mouse mammary epithelial cell line is partly mediated by T1R1/T1R3.
    Wang Y; Liu J; Wu H; Fang X; Chen H; Zhang C
    Eur J Nutr; 2017 Dec; 56(8):2467-2474. PubMed ID: 27539583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.
    Shin DH; Lee D; Hong DW; Hong SH; Hwang JA; Lee BI; You HJ; Lee GK; Kim IH; Lee YS; Han JY
    Oncotarget; 2016 Oct; 7(43):69450-69465. PubMed ID: 27626312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways.
    Qian YY; Li WY; Yan Y; Zhao XY; Yang T; Fang CC; Hou JJ; Liu YQ
    Chin J Integr Med; 2019 Nov; 25(11):845-852. PubMed ID: 31127506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of ferroptosis-related genes in sepsis-induced liver failure and analysis of immune correlation.
    Chen Q; Liu L; Ni S
    PeerJ; 2022; 10():e13757. PubMed ID: 35923893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC3A2 is a novel endoplasmic reticulum stress-related signaling protein that regulates the unfolded protein response and apoptosis.
    Liu C; Li X; Li C; Zhang Z; Gao X; Jia Z; Chen H; Jia Q; Zhao X; Liu J; Liu B; Xu Z; Tian Y; He K
    PLoS One; 2018; 13(12):e0208993. PubMed ID: 30592731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of mTOR siRNA on mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cells and the growth of transplanted tumor in nude mice].
    Liu MY; Hou GQ; Zhang Y; Bei WJ; Yan AH
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):334-9. PubMed ID: 21875460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
    Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
    Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients.
    Liang J; Sun Z
    J Oral Pathol Med; 2021 Apr; 50(4):371-377. PubMed ID: 33184944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells.
    Sui S; Zhang J; Xu S; Wang Q; Wang P; Pang D
    Cell Death Dis; 2019 Apr; 10(5):331. PubMed ID: 30988278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.
    El Ansari R; Craze ML; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
    Br J Cancer; 2018 Apr; 118(8):1115-1122. PubMed ID: 29545595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.
    Dionysopoulos D; Pavlakis K; Kotoula V; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Nikolaou A; Kalogeras KT; Fountzilas G
    Strahlenther Onkol; 2013 Mar; 189(3):202-14. PubMed ID: 23400686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.